SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-117406
Filing Date
2024-10-25
Accepted
2024-10-25 16:05:08
Documents
12
Period of Report
2024-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K meip-20241022.htm   iXBRL 8-K 48120
2 EX-2.1 meip-ex2_1.htm EX-2.1 498643
  Complete submission text file 0000950170-24-117406.txt   731541

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20241022.xsd EX-101.SCH 24867
14 EXTRACTED XBRL INSTANCE DOCUMENT meip-20241022_htm.xml XML 4705
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 241397076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)